<?xml version="1.0"?>
<Articles JournalTitle="The Research in Heart Yield and Translational Medicine (RHYTHM)">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>07</Month>
        <Day>06</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Multiple Biatrial Thromboses in a Patient with End-Stage Nonobstructive Hypertrophic Cardiomyopathy</title>
    <FirstPage>157</FirstPage>
    <LastPage>158</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Hosseinsabet</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>11</Month>
        <Day>19</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>05</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">-</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/401</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/401/483</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>11</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Left Ventricular Function after Arterial Switch Operation as Assessed by Two-Dimensional Speckle-Tracking Echocardiography in Patients with Simple Transposition of the Great Arteries</title>
    <FirstPage>105</FirstPage>
    <LastPage>110</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Elaheh</FirstName>
        <LastName>Malakan Rad</LastName>
        <affiliation locale="en_US">Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Yazdan</FirstName>
        <LastName>Ghandi</LastName>
        <affiliation locale="en_US">Amirkabir Hospital, Arak University of Medical Sciences, Arak, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Armen</FirstName>
        <LastName>Kocharian</LastName>
        <affiliation locale="en_US">Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Mirzaaghayan</LastName>
        <affiliation locale="en_US">Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: The late postoperative course for children with transposition of the great arteries (TGA) with an intact ventricular septum (IVS) is very important because the coronary arteries may be at risk of damage during&#xA0;arterial switch operation (ASO). We sought to investigate left ventricular function in patients with TGA/IVS by echocardiography.
Methods: From March 2011 to December 2012, totally 20 infants (12 males and 8 females) with TGA/IVS were evaluated via 2-dimensional speckle-tracking echocardiography (2D STE)&#xA0;more than 6 months after they underwent ASO. A control group of age-matched infants and children was also studied. Left ventricular longitudinal strain (S), strain rate (SR), time to peak systolic longitudinal strain (TPS), and time to peak systolic longitudinal strain rate (TPSR) were measured and compared between the 2 groups.
Results: Mean &#xB1; SD of age at the time of study in the patients with TGA/IVS was 15 &#xB1; 5 months, and also age at the time of ASO was 12 &#xB1; 3 days. Weight was 3.13 &#xB1; 0.07 kg at birth and 8.83 &#xB1; 1.57 kg at the time of ASO. Global strain (S), Time to peak strain rate (TPSR), and Time to peak strain (TPS) were not significantly different between the 2 groups, whereas global strain rate (SR) was significantly different (p value &lt; 0.001).&#xA0; In the 3-chamber view, the values of S in the lateral, septal, inferior, and anteroseptal walls were significantly different between the 2 groups (p value &lt; 0.001), and SR in the posterior wall was significantly different between the 2 groups (p value &lt; 0.001). There were no positive correlations between S and SR in terms of the variables of heart rate, total cardiopulmonary bypass time, and aortic cross-clamp time. There were no statistically significant differences between the 2 groups regarding S, SR, TPS, and TPSR in the anteroseptal and posterior walls in the 3-chamber view and in the lateral and septal walls in the 4-chamber view. 
Conclusion: We showed that between 6 and 18 months after a successful ASO, the parameters of S, SR, and global TPS were normal in our patients with TGA/IVS. However, LV myocardial TPSR did not normalize in this time period.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/617</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/617/472</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>11</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Myxoma Immediately above the Junction of the Inferior Vena Cava and the Right Atrium: A Rare Cause of Budd-Chiari Syndrome</title>
    <FirstPage>139</FirstPage>
    <LastPage>142</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Vahid</FirstName>
        <LastName>Mohammad Karimi</LastName>
        <affiliation locale="en_US">Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Anushiravani</LastName>
        <affiliation locale="en_US">Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Dabbaghmanesh</LastName>
        <affiliation locale="en_US">Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Massood</FirstName>
        <LastName>Hosseinzadeh</LastName>
        <affiliation locale="en_US">Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali Reza</FirstName>
        <LastName>Rasekhi</LastName>
        <affiliation locale="en_US">Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahmoud</FirstName>
        <LastName>Zamirian</LastName>
        <affiliation locale="en_US">Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The Budd&#x2013;Chiari syndrome (BCS) is a rare disorder caused by the obstruction of the hepatic veins or the inferior vena cava (IVC) at the suprahepatic level. This syndrome is developed by either hepatic vein thrombosis or mechanical venous obstruction and leads to centrilobular hepatic congestion with the subsequent development of fibrosis and cirrhosis. Intracardiac tumors have been rarely reported as a cause of the BCS. These tumors usually originate from the atrial septum. Very rarely, they arise either from the junction of the IVC and the right atrium or from the Eustachian valve. There are a few case reports in the literature where atrial tumors have caused the BCS. In these cases, the tumors were malignant, and the patients died shortly after being diagnosed. 
We describe a 71-year-old female patient who presented with a 3-month history of abdominal pain and protrusion. On physical examination, blood pressure and pulse rate were normal. Jugular venous pressure was about 10 cm. Cardiac examination revealed a systolic murmur, grade IV/VI, in the left sternal border without radiation. Echocardiography showed a large mass (about 6&#xD7;4 cm) in the right atrium with close contact to the origin of the IVC, obstructing it. Cardiac magnetic resonance imaging, with and without gadolinium, also confirmed the diagnosis. The patient underwent surgery, and the myxoma was removed. The tumor was a large solid mass, 5&#xD7;4 cm in size, which originated immediately above the entrance of the IVC. The patient is in good condition 1 year afterward. We emphasize that atrial myxomas should be considered in the differential diagnosis of tumors that cause chronic BCS.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/620</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/620/481</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>11</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Mutation Analysis of Three Exons of Myosin-Binding Protein C3 in Patients with Hypertrophic Cardiomyopathy</title>
    <FirstPage>111</FirstPage>
    <LastPage>114</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Maryam Beigom</FirstName>
        <LastName>Mobasheri</LastName>
        <affiliation locale="en_US">Medical Genetics Department, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. AND Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Modarressi</LastName>
        <affiliation locale="en_US">Medical Genetics Department, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Cirus</FirstName>
        <LastName>Darabian</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali Akbar</FirstName>
        <LastName>Zeinalou</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Hypertrophic cardiomyopathy is a genetic disorder with a prevalence rate of 0.2% in the general population. It comes from mutations in sarcomeric proteins. Cardiac myosin-binding protein C3 is one of the critical genes in hypertrophic cardiomyopathy (HCM) and sudden cardiac death, accounting for about 20% of HCM-causing mutations. Genetic testing is recommended in patients with HCM. The aim of the current study was to find possible disease-causing mutations in 3 exons of the gene myosin-binding protein C (MYBPC3) in patients with HCM. 
Methods: Fifty subjects with documented known HCM were enrolled in the study. The patients were referred to the hospitals affiliated to Tehran University of Medical Sciences between 2008 and 2011. Peripheral blood samples were collected, as well as clinical and demographic data. The nucleotide sequences of the exons number 7, 16, and 18 of MYBPC3, whose relevance to the disease was previously reported, were amplified by polymerase chain reaction. Direct DNA sequencing was applied, and the Chromas software was used to analyze the sequences to find possible disease-causing mutations.
Results: The study population comprised 73% male and 27% female patients. The mean age of the patients was 33.9 &#xB1; 20.08 years. Family history of sudden cardiac death was reported in 48.2% of the patients. About 79% of the studied subjects had a history of at least 1 other affected relative in their families. Laboratory findings did not show mutations or any nucleotide changes in the sequences of the 3 target exons in the genomic DNA of the studied patients with HCM.
Conclusion: The nucleotide sequences of the exons number 7, 16, and 18 of MYBPC3 were not mutated in the 50 studied subjects with HCM.&#xA0; &#xA0;</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/618</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/618/473</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>11</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Successful Treatment of a Left Main Thrombus by Intracoronary Eptifibatide Infusion in a 36-Year-Old Patient</title>
    <FirstPage>143</FirstPage>
    <LastPage>148</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Saeed</FirstName>
        <LastName>Alipour-Parsa</LastName>
        <affiliation locale="en_US">Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elham</FirstName>
        <LastName>Farahani</LastName>
        <affiliation locale="en_US">Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The acute coronary syndrome due to the left main coronary artery (LMCA) thrombosis is a clinically rare and catastrophic event.&#xA0; We describe a young man (smoker, alcoholic, and drug abuser) with a history of recent surgery and typical chest pain who had non-occlusive LMCA thrombosis in coronary angiography. The thrombosis was successfully treated with two 180 &#xB5;/kg intracoronary boluses of eptifibatide, which was continued through an intravenous infusion at 2 &#xB5;/kg/min for 48 hours postprocedurally. Control angiography, performed 3 days later, revealed that the LMCA was free of thrombosis. The patient had no complaints, including chest pain, and remained completely asymptomatic during the next 30 days' follow-up.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/621</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/621/476</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>07</Month>
        <Day>06</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association between Latest Activated Sites in the Left Ventricle and Akinetic Segments in Patients with Ischemic Cardiomyopathy</title>
    <FirstPage>115</FirstPage>
    <LastPage>122</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hakimeh</FirstName>
        <LastName>Sadeghian</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Aliasghar</FirstName>
        <LastName>Kousari</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shahla</FirstName>
        <LastName>Majidi</LastName>
        <affiliation locale="en_US">Emam Khomeini Hospital, Ahvaz University of Medical Sciences, Ahvaz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehrnaz</FirstName>
        <LastName>Rezvanfard</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Kazemisaeid</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Ali</FirstName>
        <LastName>Moezzi</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Vasheghani Farahani</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Abdar Esfahani</LastName>
        <affiliation locale="en_US">Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Sahebjam</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Arezoo</FirstName>
        <LastName>Zoroufian</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Afsaneh</FirstName>
        <LastName>Sadeghian</LastName>
        <affiliation locale="en_US">Shahroud University of Medical Sciences, Shahroud, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: It is not clear whether the latest activation sites in the left ventricle (LV) are matched with infracted regions in patients with ischemic cardiomyopathy (ICM). We aimed to investigate whether the latest activation sites in the LV are in agreement with the region of akinesia in patients with ICM.
Methods: Data were analyzed in 106 patients (age = 60.5 &#xB1; 12.1 y, male = 88.7%) with ICM (ejection fraction &#x2264; 35%) who were refractory to pharmacological therapy and were referred to the echocardiography department for an evaluation of the feasibility of cardiac resynchronization therapy. Wall motion abnormalities, time to peak systolic myocardial velocity (Ts) of 6 basal and 6 mid-portion segments of the LV, and 4 frequently used dyssynchrony indices were measured using 2-dimensional echocardiography and tissue Doppler imaging (TDI). To evaluate the influence of the electrocardiographic pattern, we categorized the patients into 2 groups: patients with QRS &#x2264; 120 ms and those with QRS &gt;120 ms.
Results: A total of 1 272 segments were studied. The latest activation sites (with longest Ts) were most frequently located in the mid-anterior (n = 32, 30.2%) and basal-anterior segments (n = 29, 27.4%), while the most common sites of akinesia were the mid-anteroseptal (n = 65, 61.3%) and mid-septal (n = 51, 48.1%) segments. Generally, no significant concordance was found between the latest activated segments and akinesia either in all the patients or in the QRS groups. Detailed analysis within the segments indicated a good agreement between akinesia and delayed activation in the basal-lateral segment solely in the patients with QRS duration &#x2264; 120 ms (&#x3A6; = 0.707; p value &#x2264; 0.001).
Conclusion: The akinetic segment on 2-dimensional echocardiogram was not matched with the latest activation sites in the LV determined by TDI in patients with ICM.&#xA0;</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/619</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/619/484</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2016</Year>
        <Month>11</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Anomalous Origin of the Right Coronary Artery from the Midportion of the Left Anterior Descending Artery: A Rare Coronary Anomaly</title>
    <FirstPage>149</FirstPage>
    <LastPage>152</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Arash</FirstName>
        <LastName>Gholoobi</LastName>
        <affiliation locale="en_US">Atherosclerosis Prevention Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The anomalous origin of the right coronary artery (RCA) as a branch from the left anterior descending artery (LAD) is a very rare variation of the single coronary artery anomaly. The anomalous vessel arises from the proximal or midportion of the LAD and courses anterior to the pulmonary artery trunk in most instances. In this case report, a 61-year-old woman is introduced who underwent coronary angiography following inferoposterior myocardial infarction, in which an anomalous RCA was seen originating from the midportion of the LAD. There was also a separate small artery originating from the right coronary sinus, which was most probably a right atrial branch.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/622</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/622/478</pdf_url>
  </Article>
  <Article>
    <Journal>
     "en_US">Department of Psychology and Educational Sciences, Semnan University, Semnan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shahrzad</FirstName>
        <LastName>Hoveida</LastName>
        <affiliation locale="en_US">Alborz Azad University of Sciences and Research, Karaj, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Healthy lifestyle and ineffective coping strategies are deemed significant variables among patients with hypertension. This study attempted to determine the status of these variables following intervention via the mindfulness-based stress-reduction program (MBSRP) in patients with hypertension.
Method: This study was a randomized clinical trial. The study sample, consisting of 30 patients referring to the Hypertension Clinic of Imam Hossein Hospital in 2013, was assigned either to the intervention (recipient of the MBSRP and conscious yoga) or to the control group (recipient of yoga training). The intervention group had 8 training sessions over 8 weeks. Lifestyle and coping strategies as well as blood pressure were measured in the intervention group before intervention and then immediately thereafter and at 2 months' follow-up and were compared to those in the control group at the same time points.
Result: The mean age of the patients in the intervention (40% women) and control (53% women) groups was 43.66 &#xB1; 5.14 and 43.13 &#xB1; 5.04 years, respectively. The results showed that the mean scores of lifestyle (p value &lt; 0.05), emotion-focused coping strategies (p value &lt; 0.001), problem-focused coping strategies (p value &lt; 0.001), diastolic blood pressure (p value &lt; 0.001), and systolic blood pressure (p value &lt; 0.001) were significantly different between the intervention and control groups after the intervention.
Conclusion: Applying an intervention based on the MBSRP may further improve the lifestyle and coping strategies of patients with hypertension.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/428</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/428/378</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>10</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Complication following the Transcatheter Closure of a Muscular Ventricular Septal Defect</title>
    <FirstPage>149</FirstPage>
    <LastPage>151</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mustafa</FirstName>
        <LastName>Kara&#xE7;elik</LastName>
        <affiliation locale="en_US">Department of Pediatric Cardiac Surgery, Dr. Beh&#xE7;et Uz Children&#x2019;s Hospital, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Pelin</FirstName>
        <LastName>&#xD6;zt&#xFC;rk</LastName>
        <affiliation locale="en_US">Department of Pediatric Cardiac Surgery, Dr. Beh&#xE7;et Uz Children&#x2019;s Hospital, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Onur</FirstName>
        <LastName>Doyurgan</LastName>
        <affiliation locale="en_US">Department of Pediatric Cardiac Surgery, Dr. Beh&#xE7;et Uz Children&#x2019;s Hospital, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>U&#x11F;ur</FirstName>
        <LastName>Karag&#xF6;z</LastName>
        <affiliation locale="en_US">Department of Pediatric Cardiac Surgery, Dr. Beh&#xE7;et Uz Children&#x2019;s Hospital, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Murat Muhtar</FirstName>
        <LastName>Yilmazer</LastName>
        <affiliation locale="en_US">Department of Pediatric Cardiology, Dr. Beh&#xE7;et Uz Children&#x2019;s Hospital, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Timur</FirstName>
        <LastName>Me&#x15F;e</LastName>
        <affiliation locale="en_US">Department of Pediatric Cardiology, Dr. Beh&#xE7;et Uz Children&#x2019;s Hospital, Izmir, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Osman Nejat</FirstName>
        <LastName>Sariosmano&#x11F;lu</LastName>
        <affiliation locale="en_US">Department of Pediatric Cardiac Surgery, Dr. Beh&#xE7;et Uz Children&#x2019;s Hospital, Izmir, Turkey.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Today, congenital heart diseases may be treated without surgery through advances in interventional cardiology. However, complications such as infection and thrombus formation may develop due to foreign materials used during these procedures. Surgical intervention may be required for the removal of the device utilized for the procedure. 
In this case report, we present the surgical treatment of a residual ventricular septal defect (VSD) that had developed in a 6-year-old patient with an apical muscular VSD closed with the Amplatzer muscular VSD device. The patient was admitted to the emergency room with complaints of abdominal pain and high fever 5 days after discharge without any cardiac symptoms. When she arrived at our clinic, she had a heart rate of 95 bpm, blood pressure of 110/70 mmHg, and temperature of 38.5&#xBA;C. Examinations of the other systems were normal, except for a 3/6 pan-systolic murmur at the mesocardiac focus on cardiac auscultation. Echocardiography showed a residual VSD, and the total pulmonary blood flow to the total systemic blood flow ratio (Qp/Qs) of the residual VSD was 1.8. In the operating room, the Amplatzer device was removed easily with a blunt dissection. The VSD was closed with an autologous fresh pericardial patch. Following the pulmonary artery debanding procedure, the postoperative period was uneventful. The condition of the patient at the time of discharge and in the first postoperative month&#x2019;s follow-up was good. There was no residual VSD or infection.&#xA0;</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/434</web_url>
    <pdf_url>https://jthc.tums.ac.ir/index.php/jthc/article/download/434/384</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>The Research in Heart Yield and Translational Medicine (RHYTHM)</JournalTitle>
      <Issn>3115-7270</Issn>
      <Volume>10</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Transcatheter Closure of Partially Ligated Vertical Vein after Surgical Correction of Supracardiac Total Anomalous Pulmonary Venous Connection</title>
    <FirstPage>152</FirstPage>
    <LastPage>155</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Amoozgar</LastName>
        <affiliation locale="en_US">Neonatology and Cardiac Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Ahmadipoor</LastName>
        <affiliation locale="en_US">Neonatology and Cardiac Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad Ali</FirstName>
        <LastName>Amirghofran</LastName>
        <affiliation locale="en_US">Cardiac Surgery Department, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2015</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Total anomalous pulmonary venous connection (TAPVC) is an anomaly in which the pulmonary veins are directly connected to one of the systemic veins or drain into the right atrium. Management of pulmonary hypertension after the total correction of this congenital cardiac anomaly is very important. Unligation of the vertical vein in the supracardiac type of this anomaly can be a draining pathway for the prevention of postoperative pulmonary hypertension crisis. Late onset transcatheter closure of the unligated vertical vein after a decrease in pulmonary pressure with the Amplatzer vascular plug type 1can prevent residual left-to-right shunting. Here we describe two patients who previously underwent surgical correction of supracardiac TAPVC and their vertical veinwas partially ligated due to severe pulmonary hypertension. Consequently, because of increased left-to-right shunting in the follow-up period, transcatheter occlusion of the vertical vein was done for them and this procedure seemed safe and less invasive compared to the surgical approach.At 2 years'follow-up, there was marked pulmonary artery pressure and clinical improvement.</abstract>
    <web_url>https://jthc.tums.ac.ir/index.php/jthc/article/view/435</w